Pharmacogenomics of hyaluronic acid

Abstract.Introduction: Hyaluronic acid (hyaluronan, HA) has become the most popular tool for improving the skin condition during aging, correcting wrinkles and other cosmetic defects. Objective: Analysis of the results of studies that reflect the pharmacogenomics of the synthesis, degradation, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elena E. Vaiman, Natalia A. Shnayder, Anna V. Dyuzhakova, Evgenia I. Nikitina, Olga B. Borzykh, Regina F Nasyrova
Formato: article
Lenguaje:RU
Publicado: State Scientific Center of Dermatovenereology and Cosmetology 2021
Materias:
Acceso en línea:https://doaj.org/article/e1a6a18a84cb49fe89f84110fccdaaaf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e1a6a18a84cb49fe89f84110fccdaaaf
record_format dspace
spelling oai:doaj.org-article:e1a6a18a84cb49fe89f84110fccdaaaf2021-12-01T22:16:30ZPharmacogenomics of hyaluronic acid0042-46092313-629410.25208/vdv1193https://doaj.org/article/e1a6a18a84cb49fe89f84110fccdaaaf2021-07-01T00:00:00Zhttps://vestnikdv.ru/jour/article/viewFile/1193/1206https://doaj.org/toc/0042-4609https://doaj.org/toc/2313-6294Abstract.Introduction: Hyaluronic acid (hyaluronan, HA) has become the most popular tool for improving the skin condition during aging, correcting wrinkles and other cosmetic defects. Objective: Analysis of the results of studies that reflect the pharmacogenomics of the synthesis, degradation, and reception of HA. Materials and methods: We searched for full-text publications in Russian and English in the E-Library, PubMed, Springer, Clinical keys, Google Scholar databases, using keywords and combined word searches (hyaluronic acid, hyaluronan, synthesis, degradation, reception, receptor, genetics), over the past decade. In addition, the review included earlier publications of historical interest. Despite our comprehensive searches of these commonly used databases and search terms, it cannot be excluded that some publications may have been missed. Results: The lecture examines: the role of ha in normal and aging human; genes involved in the synthesis (HAS1, HAS2, HAS3), degradation (HYAL1, HYAL2, HYAL3) and reception of ha (CD44, HARE, RHAMM); as well as the expression of their encoded proteins and enzymes in the skin. Conclusion: Expanding our knowledge of the pharmacogenomics of endogenous ha and increasing the exogenous HA drugs (used in anti-aging therapy and medical cosmetology) on the pharmaceutical market requires taking into account individual, including genetically determined, characteristics of the body of each individual patient to ensure an optimal balance of effectiveness/safety of exogenous HA from the point of view of personalized medicineElena E. VaimanNatalia A. ShnayderAnna V. DyuzhakovaEvgenia I. NikitinaOlga B. BorzykhRegina F NasyrovaState Scientific Center of Dermatovenereology and Cosmetologyarticlehyaluronanhyaluronic acidskinsynthesisreceptiondegradationpharmacogenomicspersonalized medicineanti-aging therapycosmetic dermatologyDermatologyRL1-803RUVestnik Dermatologii i Venerologii, Vol 97, Iss 3, Pp 24-38 (2021)
institution DOAJ
collection DOAJ
language RU
topic hyaluronan
hyaluronic acid
skin
synthesis
reception
degradation
pharmacogenomics
personalized medicine
anti-aging therapy
cosmetic dermatology
Dermatology
RL1-803
spellingShingle hyaluronan
hyaluronic acid
skin
synthesis
reception
degradation
pharmacogenomics
personalized medicine
anti-aging therapy
cosmetic dermatology
Dermatology
RL1-803
Elena E. Vaiman
Natalia A. Shnayder
Anna V. Dyuzhakova
Evgenia I. Nikitina
Olga B. Borzykh
Regina F Nasyrova
Pharmacogenomics of hyaluronic acid
description Abstract.Introduction: Hyaluronic acid (hyaluronan, HA) has become the most popular tool for improving the skin condition during aging, correcting wrinkles and other cosmetic defects. Objective: Analysis of the results of studies that reflect the pharmacogenomics of the synthesis, degradation, and reception of HA. Materials and methods: We searched for full-text publications in Russian and English in the E-Library, PubMed, Springer, Clinical keys, Google Scholar databases, using keywords and combined word searches (hyaluronic acid, hyaluronan, synthesis, degradation, reception, receptor, genetics), over the past decade. In addition, the review included earlier publications of historical interest. Despite our comprehensive searches of these commonly used databases and search terms, it cannot be excluded that some publications may have been missed. Results: The lecture examines: the role of ha in normal and aging human; genes involved in the synthesis (HAS1, HAS2, HAS3), degradation (HYAL1, HYAL2, HYAL3) and reception of ha (CD44, HARE, RHAMM); as well as the expression of their encoded proteins and enzymes in the skin. Conclusion: Expanding our knowledge of the pharmacogenomics of endogenous ha and increasing the exogenous HA drugs (used in anti-aging therapy and medical cosmetology) on the pharmaceutical market requires taking into account individual, including genetically determined, characteristics of the body of each individual patient to ensure an optimal balance of effectiveness/safety of exogenous HA from the point of view of personalized medicine
format article
author Elena E. Vaiman
Natalia A. Shnayder
Anna V. Dyuzhakova
Evgenia I. Nikitina
Olga B. Borzykh
Regina F Nasyrova
author_facet Elena E. Vaiman
Natalia A. Shnayder
Anna V. Dyuzhakova
Evgenia I. Nikitina
Olga B. Borzykh
Regina F Nasyrova
author_sort Elena E. Vaiman
title Pharmacogenomics of hyaluronic acid
title_short Pharmacogenomics of hyaluronic acid
title_full Pharmacogenomics of hyaluronic acid
title_fullStr Pharmacogenomics of hyaluronic acid
title_full_unstemmed Pharmacogenomics of hyaluronic acid
title_sort pharmacogenomics of hyaluronic acid
publisher State Scientific Center of Dermatovenereology and Cosmetology
publishDate 2021
url https://doaj.org/article/e1a6a18a84cb49fe89f84110fccdaaaf
work_keys_str_mv AT elenaevaiman pharmacogenomicsofhyaluronicacid
AT nataliaashnayder pharmacogenomicsofhyaluronicacid
AT annavdyuzhakova pharmacogenomicsofhyaluronicacid
AT evgeniainikitina pharmacogenomicsofhyaluronicacid
AT olgabborzykh pharmacogenomicsofhyaluronicacid
AT reginafnasyrova pharmacogenomicsofhyaluronicacid
_version_ 1718404133528010752